Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

VMD highlights concerns about needle stick injuries
injection
Needle stick injuries continue to be seen in those who administer medicines to large and small animals.
Vaccines with mineral oil adjuvant ‘of particular concern’ - annual report

The Veterinary Medicines Directorate (VMD) has highlighted concerns about needle stick injuries, and dogs ingesting medicines meant for large animals, in its latest pharmacovigilance report.

In 2015 the VMD received 5,674 reports of adverse events in animals, humans and the environment, following the use of veterinary medicines. This represents a slight decrease from the previous year. While there was a fall in the number of reports for food-producing animals, pet animal reports increased in number.

The majority of reports were spontaneous (5,638), arising from the everyday use of veterinary medicines. There were 5,512 reports relating to animals, 124 to humans and two involving the environment. Most occurred in animals either during or after the use of authorised veterinary or human medicines, and many reports involved a combination of products.

Out of the 124 human events, 19 were veterinary surgeons; six were other health professionals, usually veterinary nurses; 21 were animal tenders, mostly farm workers; and 78 were pet or large animal owners, or others who came into contact with their animals.

Needle stick injuries continue to be seen in those who administer medicines to large and small animals. Of particular concern, the VMD noted, are events involving vaccines with mineral oil adjuvant. Often, reports fail to show that the affected person has received prompt and correct treatment, either because they are unaware of the need for swift treatment, or because they did not take the packaging with them when they sought help.

Similarly, events involving injectable tilmicosin were often dismissed as “just a scratch”. If these products are used, the veterinary surgeon must be fully aware of the the warnings contained in product leaflets, the VMD said.

The report also raises concerns about dogs ingesting anything found on the ground near to where large animals are treated and kept. In 2015 several dogs died after chewing regurgitated monensin cattle boli. Several others were affected after eating horse dung that may have contained residues of parasiticide medication, or chewing discarded dosing syringes.

Many of the adverse event reports involving horses related to the use of euthanasia products that did not perform as expected. An alternative means of euthanasia must always be available to ensure the welfare of the animal and the safety of people in the vicinity, VMD said.

The full report can be found here: https://www.gov.uk/government/news/veterinary-medicines-pharmacovigilance-annual-review-2015-summary

Become a member or log in to add this story to your CPD history

Annual submission deadline small pet animal exemptions

News Story 1
 Companies marketing medicines for small pets exempt from authorisation must submit their annual return to the Veterinary Medicines Directorate (VMD) by 30 November 2026.

Submitting this annual return ensures continued compliance with regulatory requirements for products marketed without a full Marketing Authorisation. The exemption specifically applies to products intended for animals, cage birds, terrarium animals, small rodents, ferrets and rabbits.

For further details and submission guidelines, visit the gov.uk website.  

Click here for more...
News Shorts
Bluetongue RZ extended across Scotland

The Scottish Government has announced an extension to a Bluetongue Restricted Zone that is in place in south-west Scotland.

From 3 October, the Restricted Zone will be extended to cover the whole of Scotland. The Animal, Plant and Health Agency (APHA) says this is in response to further disease spread, as well as simplify trading conditions ahead of the autumn.

Since the whole country will share a disease status, it will no longer be necessary to have a movement license to move susceptible livestock around the country. Restrictions on germinal products remain.

As of 1 October 2026, there were 1,979 cases of BTV-3 in England, 389 cases in Wales and 40 cases in Scotland.